These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23627635)

  • 41. Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications.
    Bhaijee F; Pepper DJ; Pitman KT; Bell D
    Head Neck; 2012 Jun; 34(6):894-9. PubMed ID: 21850700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cell characteristics of cell sub-populations in cell lines derived from head and neck cancers of Fanconi anemia patients.
    Gammon L; Biddle A; Fazil B; Harper L; Mackenzie IC
    J Oral Pathol Med; 2011 Feb; 40(2):143-52. PubMed ID: 21138479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMM.
    Shigeishi H; Biddle A; Gammon L; Emich H; Rodini CO; Gemenetzidis E; Fazil B; Sugiyama M; Kamata N; Mackenzie IC
    Stem Cells; 2013 Oct; 31(10):2073-83. PubMed ID: 23649588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells.
    Chikamatsu K; Ishii H; Takahashi G; Okamoto A; Moriyama M; Sakakura K; Masuyama K
    Head Neck; 2012 Mar; 34(3):336-43. PubMed ID: 21472882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.
    Czerwinski MJ; Desiderio V; Shkeir O; Papagerakis P; Lapadatescu MC; Owen JH; Athanassiou-Papaefthymiou M; Zheng L; Papaccio G; Prince ME; Papagerakis S
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):97-104. PubMed ID: 23558285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics.
    Gilormini M; Wozny AS; Battiston-Montagne P; Ardail D; Alphonse G; Rodriguez-Lafrasse C
    J Vis Exp; 2016 May; (111):. PubMed ID: 27213496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of cancer stem cells from head and neck squamous cell carcinoma cell lines.
    Pozzi V; Sartini D; Rocchetti R; Santarelli A; Rubini C; Morganti S; Giuliante R; Calabrese S; Di Ruscio G; Orlando F; Provinciali M; Saccucci F; Lo Muzio L; Emanuelli M
    Cell Physiol Biochem; 2015; 36(2):784-98. PubMed ID: 26021266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway.
    Lim YC; Kang HJ; Kim YS; Choi EC
    Eur J Cancer; 2012 Nov; 48(17):3310-8. PubMed ID: 22640830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer stem cells in head and neck squamous cell carcinoma.
    Szafarowski T; Szczepanski MJ
    Otolaryngol Pol; 2014; 68(3):105-11. PubMed ID: 24837904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties.
    Martens-de Kemp SR; Brink A; Stigter-van Walsum M; Damen JM; Rustenburg F; Wu T; van Wieringen WN; Schuurhuis GJ; Braakhuis BJ; Slijper M; Brakenhoff RH
    Stem Cell Res; 2013 May; 10(3):477-88. PubMed ID: 23523931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Grau JJ; Mesía R; de la Iglesia-Vicente M; Williams ES; Taberna M; Caballero M; Larque AB; de la Oliva J; Cordón-Cardo C; Domingo-Domenech J
    Oncology; 2016; 90(5):267-72. PubMed ID: 27077749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and genomic characterization of stem cells in head and neck cancer.
    Wilson GD; Marples B; Galoforo S; Geddes TJ; Thibodeau BJ; Grénman R; Akervall J
    Head Neck; 2013 Nov; 35(11):1573-82. PubMed ID: 23108794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between CD44
    Silva Galbiatti-Dias AL; Fernandes GMM; Castanhole-Nunes MMU; Hidalgo LF; Nascimento Filho CHV; Kawasaki-Oyama RS; Ferreira LAM; Biselli-Chicote PM; Pavarino ÉC; Goloni-Bertollo EM
    Am J Cancer Res; 2018; 8(8):1633-1641. PubMed ID: 30210931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy.
    Baumann M; Krause M
    Clin Cancer Res; 2010 Nov; 16(21):5091-3. PubMed ID: 20861165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.
    Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S
    Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells.
    Cho KJ; Park EJ; Kim MS; Joo YH
    Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin Results in Diametrically Opposed Effects by Targeting Non-Stem Cancer Cells but Protecting Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma.
    Kuo SZ; Honda CO; Li WT; Honda TK; Kim E; Altuna X; Abhold E; Wang-Rodriguez J; Ongkeko WM
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.
    Ren L; Deng B; Saloura V; Park JH; Nakamura Y
    Oncol Rep; 2019 Apr; 41(4):2540-2548. PubMed ID: 30720113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.
    Perez A; Neskey DM; Wen J; Pereira L; Reategui EP; Goodwin WJ; Carraway KL; Franzmann EJ
    Oral Oncol; 2013 Apr; 49(4):306-13. PubMed ID: 23265944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.